Kick-Nic! Youth Quit Vaping App
Vaping Cessation Among Youth: Evaluating the Kick-Nic! App
2 other identifiers
interventional
306
1 country
1
Brief Summary
High school students who want to quit vaping will be randomized to receive the Kick-Nic! app or a control NCI website to determine the efficacy of the app for vaping cessation. Participants will be screened for eligibility, then go through an 8 week treatment period where they will be given access to use the Kick-Nic! app or referred to the NCI Quit Vaping website. This will be followed by 1, 2, 3, and 6 month follow up visits. Qualitative interviews with participants and school staff will also be conducted to obtain feedback on the app and best ways to implement/disseminate the app. Abstinence rates will be assessed biweekly during treatment including at end of treatment (EOT), and then at 1, 2, 3 and 6 month follow ups (FU). Biochemical verification (salivary cotinine \< 30 ng.ml) of self-reports of abstinence will be conducted at EOT and 6-month FU.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Jan 2025
Typical duration for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2024
CompletedFirst Posted
Study publicly available on registry
October 28, 2024
CompletedStudy Start
First participant enrolled
January 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 31, 2029
January 28, 2026
January 1, 2026
4.6 years
October 16, 2024
January 26, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Timeline Follow Back (self-report) with saliva cotinine (biochemical verification) at 6 month follow up.
Timeline Follow Back (self-report) determining 7-day point prevalence of e-cigarette use confirmed by saliva cotinine \<30ng/mL at 6 month follow up visit.
6 month follow up study visit.
Secondary Outcomes (2)
Timeline Follow Back (self-report) with saliva cotinine (biochemical verification) at End of Treatment (EOT).
EOT (8 weeks).
Timeline Follow Back (self-report) at EOT, 3, and 6 month follow up
EOT (8 weeks), 3 month follow up, and 6 month follow up.
Study Arms (2)
ACTIVE
EXPERIMENTALParticipants in the active group will be given access to the Kick-Nic! app to use for vaping cessation.
CONTROL
ACTIVE COMPARATORParticipants in the control group will be referred to the NCI Quit Vaping website.
Interventions
The Kick-Nic! app has seven modules that cover core CBT strategies using skills, graphic illustrations, and interactive components to help adolescents quit using e-cigarettes.
The NCI webpage provides quitting tobacco resources for youth, including for e-cigarettes. The information provided is similar to the CBT skills modeled by the Kick-Nic! app.
Eligibility Criteria
You may qualify if:
- high school aged youth (13-19 years old),
- regular current (past month) e-cig users using nicotine-containing e-cigs at least 1 day/week.
- want to quit using e-cigarettes.
- have a smartphone with data/WIFI plan in order to access and utilize the KickNic! app
You may not qualify if:
- Those who have non-stable (\<2 months) use of anxiolytics, antidepressants, and other psychostimulants or have a history of psychosis or any significant current psychiatric/medical condition that would increase risk will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- National Cancer Institute (NCI)collaborator
- Yale Universitylead
Study Sites (1)
Yale University School of Medicine (Connecticut Mental Health Center)
New Haven, Connecticut, 06519, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Suchitra Krishnan-Sarin, Ph.D.
Yale University School of Medicine, Dept of Psychiatry
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 16, 2024
First Posted
October 28, 2024
Study Start
January 16, 2025
Primary Completion (Estimated)
August 31, 2029
Study Completion (Estimated)
August 31, 2029
Last Updated
January 28, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share
De-identified individual participant data that underlie results in a publication may be shared with other researchers.